RECRUITING
I'm interested ...!!
Pediatric Cardiomyopathy Mutation Analysis
The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of this disorder. This will provide the basis for future genetic counseling as well as contribute to elucidating the biology of normal and abnormal cardiac function.
Conditions:
🦠 Cardiomyopathies 🦠 Dilated Cardiomyopathy 🦠 Hypertrophic Cardiomyopathy 🦠 Restrictive Cardiomyopathy 🦠 Arrhythmogenic Right Ventricular Cardiomyopathy 🦠 Left Ventricular Non-compaction Cardiomyopathy
🗓️ Study Start (Actual) April 2014
🗓️ Primary Completion (Estimated) 31 December 2030
✅ Study Completion (Estimated) 31 December 2030
👥 Enrollment (Estimated) 300
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Indianapolis, Indiana, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Subjects with cardiomyopathy
    • * Family members of subjects with cardiomyopathy

    Exclusion Criteria:

    • * Subjects without cardiomyopathy
    • * Family members of subjects without cardiomyopathy
Ages Eligible for Study: N/A to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 28 April 2015
  • First Submitted that Met QC Criteria 28 April 2015
  • First Posted 1 May 2015

Study Record Updates

  • Last Update Submitted that Met QC Criteria 5 February 2024
  • Last Update Posted 7 February 2024
  • Last Verified February 2024
I'm interested ...!!